发明授权
- 专利标题: Sustained release parenteral formulations of buprenorphine
- 专利标题(中): 丁丙诺啡的持续释放非肠道制剂
-
申请号: US12636227申请日: 2009-12-11
-
公开(公告)号: US08455508B2公开(公告)日: 2013-06-04
- 发明人: Carmela Luangdilok , Douglas R. Flanagan , Luk-Chiu Li , Matthew Widman
- 申请人: Carmela Luangdilok , Douglas R. Flanagan , Luk-Chiu Li , Matthew Widman
- 申请人地址: US IL Abbott Park
- 专利权人: Abbott Laboratories
- 当前专利权人: Abbott Laboratories
- 当前专利权人地址: US IL Abbott Park
- 代理机构: Michael Best & Friedrich LLP
- 代理商 Lisa V. Mueller
- 主分类号: A01N43/42
- IPC分类号: A01N43/42 ; A61K31/44
摘要:
An oil-in-water buprenorphine formulation including buprenorphine and a surfactant that emulsifies the buprenorphine in oil, wherein the drug release is controlled by varying the oil concentration and/or pH. A buprenorphine aqueous suspension formulation including a free base buprenorphine and a suspension stabilizer. A buprenorphine oil formulation including a buprenorphine salt suspended in a pharmaceutically acceptable oil. Methods of providing sustained release of buprenorphine over a period of time.
公开/授权文献
信息查询
IPC分类: